Cargando…

Long-Term Persistence of Olfactory and Gustatory Disorders in COVID-19 Patients

Mostrar otras versiones (1)

Smell and taste disorders are frequent symptoms during acute COVID-19 and may persist long after the resolution of the initial phase. This study aims to estimate the proportion and risk factors for smell and/or taste disorders at the onset of symptoms and their persistence after more than 6 months o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Nhu Ngoc, Hoang, Van Thuan, Dao, Thi Loi, Meddeb, Line, Cortaredona, Sébastien, Lagier, Jean-Christophe, Million, Matthieu, Raoult, Didier, Gautret, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915119/ https://www.ncbi.nlm.nih.gov/pubmed/35280874 http://dx.doi.org/10.3389/fmed.2022.794550

Ejemplares similares

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2021)

Long-term persistence of symptoms of dyspnoea in COVID-19 patients
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
por: Dao, Thi Loi, et al.
Publicado: (2021)

Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis
por: Dao, Thi Loi, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Olfactory and gustative disorders for the diagnosis of COVID-19
por: Boudjema, Sophia, et al.
Publicado: (2020)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to advances statistical methods and designs for clinical trials for COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2023)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Evaluation of pain susceptibility by taking blood pressure in patients with infections: A prospective comparative study
por: Eldin, Carole, et al.
Publicado: (2021)

Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France
por: Hoang, Van-Thuan, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review
por: Dao, Thi Loi, et al.
Publicado: (2020)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Introduction of the SARS-CoV-2 Beta variant from Comoros into the Marseille geographical area
por: Hoang, Van Thuan, et al.
Publicado: (2022)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Simultaneity judgment using olfactory–visual, visual–gustatory, and olfactory–gustatory combinations
por: Gotow, Naomi, et al.
Publicado: (2017)

Epidemiology of human common coronavirus acquisition in pilgrims
por: Dao, Thi Loi, et al.
Publicado: (2020)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Epidemiological Investigations of Infectious Diseases among Mobile Populations at the University Hospital Institute Mediterranean Infection in Marseille, France
por: Dao, Thi Loi, et al.
Publicado: (2021)

Pneumococcal infections and homelessness
por: LY, TRAN DUC ANH, et al.
Publicado: (2022)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Risk factors for symptoms of infection and microbial carriage among French medical students abroad
por: Dao, Thi Loi, et al.
Publicado: (2020)

Corrigendum to “Risk factors for symptoms of infection and microbial carriage among French medical students abroad” [International Journal of Infectious Diseases, Vol 100 (2020) Pages 104-111]
por: Dao, Thi Loi, et al.
Publicado: (2023)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhône District, Southern France, 2021
por: Fournier, Pierre-Edouard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vfjaqf86pgjm8ib9cfoi0qqvfi